{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T15:43:27Z","timestamp":1773157407087,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1038\/nm1002-1086","type":"journal-article","created":{"date-parts":[[2002,9,30]],"date-time":"2002-09-30T15:44:22Z","timestamp":1033400662000},"page":"1086-1087","source":"Crossref","is-referenced-by-count":12,"title":["EBV framed in Burkitt lymphoma"],"prefix":"10.1038","volume":"8","author":[{"given":"Samuel H.","family":"Speck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnm10021086_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1098\/rstb.2000.0783","volume":"356","author":"DH Crawford","year":"2001","unstructured":"Crawford, D.H. Biology and disease associations of Epstein\u2013Barr virus. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 356, 461\u2013473 (2001).","journal-title":"Philos. Trans. R. Soc. Lond. B. Biol. Sci."},{"key":"BFnm10021086_CR2","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/nm758","volume":"8","author":"G Kelly","year":"2002","unstructured":"Kelly, G., Bell, A. & Rickinson, A. Epstein\u2013Barr virus\u2013associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. Nature Med. 8, 1098\u20131104 (2002).","journal-title":"Nature Med."},{"key":"BFnm10021086_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/35095584","volume":"1","author":"DA Thorley-Lawson","year":"2001","unstructured":"Thorley-Lawson, D.A. Epstein\u2013Barr virus: Exploiting the immune system. Nature Rev. Immunol. 1, 75\u201382 (2001).","journal-title":"Nature Rev. Immunol."},{"key":"BFnm10021086_CR4","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/313812a0","volume":"313","author":"JL Yates","year":"1985","unstructured":"Yates, J.L., Warren, N. & Sugden, B. Stable replication of plasmids derived from Epstein\u2013Barr virus in various mammalian cells. Nature 313, 812\u2013815 (1985).","journal-title":"Nature"},{"key":"BFnm10021086_CR5","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0092-8674(95)90489-1","volume":"80","author":"G Mosialos","year":"1995","unstructured":"Mosialos, G. et al. The Epstein\u2013Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80, 389\u2013399 (1995).","journal-title":"Cell"},{"key":"BFnm10021086_CR6","doi-asserted-by":"publisher","first-page":"7070","DOI":"10.1002\/j.1460-2075.1996.tb01098.x","volume":"15","author":"U Zimber-Strobl","year":"1996","unstructured":"Zimber-Strobl, U. et al. Epstein\u2013Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival. EMBO J. 15, 7070\u20137078 (1996).","journal-title":"EMBO J."},{"key":"BFnm10021086_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1074-7613(00)80623-8","volume":"9","author":"RG Caldwell","year":"1998","unstructured":"Caldwell, R.G., Wilson, J.B., Anderson, S.J. & Longnecker, R. Epstein\u2013Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals. Immunity 9, 405\u2013411 (1998).","journal-title":"Immunity"},{"key":"BFnm10021086_CR8","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1074-7613(00)00049-2","volume":"13","author":"GJ Babcock","year":"2000","unstructured":"Babcock, G.J., Hochberg, D. & Thorley-Lawson, A.D. The expression pattern of Epstein\u2013Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity 13, 497\u2013506 (2000).","journal-title":"Immunity"},{"key":"BFnm10021086_CR9","doi-asserted-by":"crossref","first-page":"9959","DOI":"10.1128\/JVI.73.12.9959-9968.1999","volume":"73","author":"EJ Paulson","year":"1999","unstructured":"Paulson, E.J. & Speck, S.H. Differential methylation of Epstein\u2013Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. J. Virol. 73, 9959\u20139968 (1999).","journal-title":"J. Virol."},{"key":"BFnm10021086_CR10","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1073\/pnas.072495599","volume":"99","author":"MS Staege","year":"2002","unstructured":"Staege, M.S. et al. MYC overexpression imposes a nonimmunogenic phenotype on Epstein\u2013Barr virus-infected B cells. Proc. Natl. Acad. Sci. USA 99, 4550\u20134555 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm10021086_CR11","first-page":"175","volume-title":"Epstein\u2013Barr Virus Report","author":"LI Yoo","year":"2002","unstructured":"Yoo, L.I. & Speck, S.H. Regulation of EBNA gene expression. Epstein\u2013Barr Virus Report 7, 175\u2013185 (2002)."},{"key":"BFnm10021086_CR12","doi-asserted-by":"publisher","first-page":"7568","DOI":"10.1073\/pnas.91.16.7568","volume":"91","author":"SR Grossman","year":"1994","unstructured":"Grossman, S.R., Johannsen, E., Tong, X., Yalamanchili, R. & Kieff, E. The Epstein\u2013Barr virus nuclear antigen 2 transactivator is directed to response elements by the J\u03ba recombination signal binding protein. Proc. Natl. Acad. Sci. USA 91, 7568\u20137572 (1994).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm10021086_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1126\/science.8016657","volume":"265","author":"T Henkel","year":"1994","unstructured":"Henkel, T., Ling, P.D., Hayward, S.D. & Peterson, M.G. Mediation of Epstein\u2013Barr virus EBNA2 transactivation by recombination signal-binding protein J\u03ba. Science 265, 92\u201395 (1994).","journal-title":"Science"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm1002-1086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1002-1086","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm1002-1086.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:37:14Z","timestamp":1684453034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm1002-1086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["BFnm10021086"],"URL":"https:\/\/doi.org\/10.1038\/nm1002-1086","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}